498 filings
Page 7 of 25
6-K
vfgiw7wey1osu
16 Nov 23
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
9:03am
6-K
y21x 2sifac
16 Nov 23
Third Quarter Interim Statement JANUARY – SEPTEMBER 2023
6:00am
6-K
rpluhrbku94hddemd66
14 Nov 23
Current report (foreign)
10:28am
6-K
x11rhzy7neibt4nhd8oc
13 Nov 23
Current report (foreign)
10:07am
6-K
pbj4pr1rg7ey8
13 Nov 23
Current report (foreign)
6:25am
6-K
vw0gt hhxnsd
9 Nov 23
Current report (foreign)
10:32am
6-K
3s62fd 5bza3
7 Nov 23
Current report (foreign)
10:05am
6-K
lr4i1ejtveqyalq4vd3y
2 Nov 23
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
9:20am
6-K
hzeiow8egkvexdhc
27 Oct 23
Current report (foreign)
10:26am
6-K
b15qjsztils1zeus9kfg
26 Oct 23
Current report (foreign)
10:06am
6-K
jab16d
25 Oct 23
Current report (foreign)
11:28am
6-K
4a0og27 bpnl6tqoritj
25 Oct 23
Current report (foreign)
10:30am
6-K
2nu5v 5nwf
24 Oct 23
Current report (foreign)
10:08am
6-K
875eh
23 Oct 23
Current report (foreign)
10:48am
6-K
axm3sin6
19 Oct 23
Current report (foreign)
10:19am
6-K
z953muldz4 ms
18 Oct 23
Current report (foreign)
11:04am
6-K
f7fuljgxxzqzo7i
16 Oct 23
Current report (foreign)
10:13am
6-K
3ylw1vmqub4lwogw1jts
10 Oct 23
Current report (foreign)
10:07am
6-K
ns79kzq5 gnl
10 Oct 23
Current report (foreign)
9:15am
6-K
kengwa mf
5 Oct 23
Current report (foreign)
10:07am